a KA (Kaletra 200 mg / 50 mg)
Generic Name: lopinavir/ritonavir
Pill imprint a KA has been identified as Kaletra 200 mg / 50 mg.
Kaletra is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy. Kaletra 200 mg / 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for a KA
- Generic Name:
- 200 mg / 50 mg
- 19.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Abbott Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
- sorbitan monolaurate
silicon dioxide colloidal
sodium stearyl fumarate
polyethylene glycol 400
polyethylene glycol 3350
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54569-5752||A S Medication Solutions LLC (repackager)|
|54868-5566||Physicians Total Care Inc (repackager)|
|55045-3482||Dispensing Solutions Inc. (repackager)|
|55289-0947||PDRX Pharmaceuticals Inc (repackager)|
|00490-7028||Southwood Pharmaceuticals Inc (repackager)|
|35356-0112||Lake Erie Medical and Surgical Supply (repackager)|
|21695-0362||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about Kaletra (lopinavir / ritonavir)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.